In a previous study, the investigators found that HOXC6 and DLX1 associate with different prostate tumor-specific enhancer clusters and confer distinct transcriptomic changes on C42B prostate cancer cells, which play a role in prostate tumor development (20). This evidence concerns the gene DLX1 and prostate neoplasm.